Mirror Site, please visit our main site www.timtec.com

Text Size

Featured

Uncategorised

Display # 
Title
About TimTec
Plants in Stock from A to B
Plants in Stock from C to F
Thank You
Inquiry Received
Partners
ActiProbe-10K
Photogem
AG-205, Pgrmc1 Inhibitor
Contract Research Services
ActiTarg-N, Nuclear Receptor Ligands
Distributors
Activity-Aimed Sets
Flavonoid Derivatives
Aryl Hydrocarbon Receptor (AhR) Ligands - Virtual Screen Results
ActiProbe Series
FBL - Fragment-Based Library
Grants and Funding Web Resources
__404__
ChemSubscriber +
Gossypol Derivatives
Featured Natural Compounds
NDL-3000 Natural Derivatives Library
MELITTIN MSDS
MELITTIN Certificate of Analysis
Mellitin Analytical Data
Mellitin References
Mellitin
MyriaScreen Drug Like Statistics
Gossypol MSDS
Gossypol Certificate of Analysis
Gossypol and Derivatives
Genipin
Activators of Neutrophils
Inhibitors of Anthrax LF
Monastrol Certificate of Analysis
Monastrol MSDS
Monastrol Reference
ActiCom Collection of Active Compounds
2-Chloro-4-nitro Imidazole
MaxiVerse Molecular Diversity Libraries
O-GlcNAc Transferase Inhibitors
Serine Proteinase Inhibitors - ActiTarg-S Library
Biotinylation Reagents & Labels
Building Blocks and Intermediates
Chemical and Analytical Products
Plants in Stock from S to Z
Plants in Stock from M to R
Plants in Stock from D to L
Plants in Stock from G to L
Services
Custom Synthesis
Compound Management and Acquisition
Sample Handling - Weighting, Plating, Compound Library Management
Cheminformatics Services
Molecular Diversity and Similarity Analysis
ActiProbe-10K Library
ApexScreen Compound Library
Diversity Screening Set 10K
Rare-CSC - Historic collection of diverse, drug-like compounds.
Natural Compound Library
ActiGlobe-50K
ActiProbe-25K
Kinase Modulators - ActiTarg-K Library
Protease Inhibitors - ActiTarg-P Library
MyriaScreen Diversity Collection
Anti-Infectives
ActiTarg-I Potassium Channel Modulators
Updated Compound Databases
Plants in Stock from A to C
Targeted Compound Libraries
Privileged Structure Library
Diversity Compound Libraries
Plant Extracts
Natural Products
Template-Based Compound Libraries
Screening Compound Libraries
404
Terms of Sale

Database Access

Contact Us

P: 302-292-8500
F: 302-292-8520
This e-mail address is being protected from spambots. You need JavaScript enabled to view it.

eStore Product Search

IUPAC, Smiles, ID, MW, Name, CAS, MDL

Follow Us Message Us Friend Us Friend Us

eChemShop Chemicals, Equipment, Software

ChemDBsoft Chemical Database Software

Drug Discovery News

  • Osiris Therapeutics’ adult stem cell therapy Prochymal® received approval from Health Canada for the treatment of acute graft-vs-host disease (GvHD) in children who failed to respond to steroids. The company will have to carry out certain post-launch confirmatory studies. The decision gives Osiris the distinction of being the first company to win full marketing approval [...]

  • Scientists have adapted the algorithm used by Google’s web search engine to develop a computational program that can identify panels of biomarkers for cancer prognosis. Google’s PageRank algorithm takes into account the network of hyperlinks between web documents as well as the search terms themselves to determine which pages are most relevant to a particular [...]

  • Janssen Pharmaceuticals reported Phase III results demonstrating the efficacy of Nucynta® ER (extended release tapentadol) in managing pain associated with chronic diabetic peripheral neuropathy (DPN). Janssen says the data is consistent with that of a separate study reported in 2011 in patients with DPN. Nucynta ER is a centrally acting analgesic that acts as both [...]

  • Targeted cancer drug developer Ruga negotiated rights to Selexagen Therapeutics’ RAF kinase program. The firm claims the acquired technology addresses the drawbacks to BRAF inhibition as an approach to cancer therapy. Data has demonstrated that BRAF inhibition can actually induce adaptation in RAS-activated cells and promote the development of secondary skin lesions and RAS-mutated tumor [...]

  • XenoBiotic Laboratories established a partnership with Hungary-based Solvo Biotechnology to offer in vitro transporter services in the U.S. Solvo will transfer its efflux and uptake transporter assays to XBL’s research facilities in New Jersey. The services will be made available to American customers through both Solvo and XBL sales channels. Through this collaboration Solvo will [...]

  • Affymetrix signed a worldwide distribution agreement for ScreenCell’s isolation devices and dilution buffers for the collection of circulating tumor cells (CTCs) in peripheral blood. The QuantiGene® ViewRNA CTC platform, which consists of ScreenCell’s products and Affymetrix’ QuantiGene ViewRNA Assays, is now available from Affymetrix. The arrangement makes Affymetrix the exclusive distributor of ScreenCell products used [...]

  • An algal system for manufacturing recombinant proteins has provided scientists with the means to generate a malaria-blocking vaccine candidate based on two native unglycosylated Plasmodium falciparum surface proteins, Pfs25 and Pfs28. The University of California, San Diego researchers produced the two P. falciparum proteins in the chloroplasts of the widely used model alga Chlamydomonas reinhardtii, [...]

  • Agilent is buying Danish cancer in vitro diagnostics firm Dako for $2.2 billion in cash on a debt-free basis. Agilent says the acquisition is the largest in its history, and will complement its existing life science business and boost its presence in the clinical diagnostics market. “In the rapidly growing diagnostics market, Dako’s products and [...]

  • Aveo Oncology and partner Astellas Pharma Europe reported positive data from the pivotal Phase III study Viro-1, comparing the once-daily oral tyrosine kinase inhibitor candidate tivozanib with sorafenib in 517 patients with advanced renal cell carcinoma (RCC). Astellas says it plans to submit a marketing authorization application for tivozanib to the European authorities during the [...]

  • Evotec is adding Agilent Technologies’ RapidFire mass spectrometry analysis capabilities to its high-throughput screening facilities in Hamburg. RapidFire is an in-line solid-phase extraction technology. It enables ultrafast, direct analysis of native compounds for a variety of biochemical assays including routine ADME and lead discovery applications across a range of therapeutic areas. Evotec reports that it [...]